Market Overview:
The global immunofluorescence assays market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for immunofluorescence assays in the clinical research and laboratory diagnostics applications. The increasing prevalence of various diseases, such as cancer, is also contributing to the growth of this market. The global immunofluorescence assays market by type is segmented into antibodies, kits and reagents, labeling dyes, and species type. The antibodies segment is expected to account for the largest share of this market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing demand for antibody-based products for various applications such as clinical research and laboratory diagnostics. The global immunofluorescence assays market by application is divided into clinical research and laboratory diagnostics segments. The clinical research application segment accounted for the largest share of this market in 2017 owingtothe growing use of theseassaysin drug development studiesforthe detection offunctional proteins associated with diseases.
Product Definition:
Immunofluorescence assays are a type of immunoassay that uses fluorescence to detect antibodies or antigens. Immunofluorescence assays are used to detect and quantify proteins and other biomolecules. The importance of immunofluorescence assays lies in their ability to specifically detect target molecules in a complex sample while minimizing background noise.
Antibodies:
Antibodies are proteins, which are produced by B cells and antibodies have a wide range of applications in the medical field. Antibodies can be used for diagnosis of diseases such as diabetes, cancer and other autoimmune disorders. They also play an important role in drug discovery process.
Kits and reagents:
Kits and reagents are used for performing immunofluorescence assays. Immunofluorescence assay is a procedure where antibodies are used to identify the presence of a particular protein in cells or tissues. It is widely applied in research and diagnostic laboratories for the detection of cancer, infections, autoimmune diseases, neurological disorders as well as various other medical conditions.
Application Insights:
The application segment is sub-divided into clinical research and laboratory diagnostics. In 2017, the clinical research segment dominated the global immunofluorescence assays market with a share of over 80%. The growth can be attributed to an increase in R&D activities pertaining to new drug development for various chronic diseases.
Moreover, increasing government funding for cancer research coupled with growing awareness about immunotherapy are further expected to drive the growth of this segment during the forecast period. On the other hand, laboratory diagnostics is anticipated to witness a lucrative CAGR during the forecast period owing to an increase in demand for rapid testing methods that assist healthcare professionals in making decisions regarding patient treatment quickly. This method also helps detect infectious agents such as viruses and bacteria that may be present in low quantities but still cause concern due to their potential etiology or infection source.
Regional Analysis:
North America dominated the global immunofluorescence assays market in 2017. This can be attributed to the presence of a large number of biotechnology and pharmaceutical companies, which are engaged in R&D for immunological disorders. Moreover, increasing prevalence of cancer is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by government and private entities for development of healthcare infrastructure including diagnostic laboratories and hospitals.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Technological advancements in immunofluorescence assay kits and instruments
- Growing number of research studies on immunofluorescence assays
- Increasing use of immunofluorescence assays in drug discovery and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunofluorescence Assays Market Research Report
By Type
Antibodies, Kits and reagents, Labeling dyes, Species type
By Application
Clinical Research, Laboratory Diagnostics
By Companies
Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), Vector Laboratories (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Immunofluorescence Assays Market Report Segments:
The global Immunofluorescence Assays market is segmented on the basis of:
Types
Antibodies, Kits and reagents, Labeling dyes, Species type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Research, Laboratory Diagnostics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher (US)
- Inova Diagnostics (US)
- Bio-Rad (US)
- Abcam (UK)
- PerkinELmer (US)
- Merck Millipore (US)
- Cell Signaling Technology (US)
- MEDIPAN GMBH (Germany)
- Sino Biological (China)
- Danaher (US)
- Vector Laboratories (US)
Highlights of The Immunofluorescence Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibodies
- Kits and reagents
- Labeling dyes
- Species type
- By Application:
- Clinical Research
- Laboratory Diagnostics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunofluorescence Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immunofluorescence assays are a type of laboratory test that uses antibodies to identify specific proteins or cells in a sample. The antibodies attach to the target protein or cell and then fluoresce under ultraviolet light, making it easy to see which proteins or cells are present.
Some of the key players operating in the immunofluorescence assays market are Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), Vector Laboratories (US).
The immunofluorescence assays market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunofluorescence Assays Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunofluorescence Assays Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunofluorescence Assays Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunofluorescence Assays Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunofluorescence Assays Market Size & Forecast, 2020-2028
4.5.1 Immunofluorescence Assays Market Size and Y-o-Y Growth
4.5.2 Immunofluorescence Assays Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibodies
5.2.2 Kits and reagents
5.2.3 Labeling dyes
5.2.4 Species type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinical Research
6.2.2 Laboratory Diagnostics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunofluorescence Assays Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunofluorescence Assays Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibodies
9.6.2 Kits and reagents
9.6.3 Labeling dyes
9.6.4 Species type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinical Research
9.10.2 Laboratory Diagnostics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibodies
10.6.2 Kits and reagents
10.6.3 Labeling dyes
10.6.4 Species type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinical Research
10.10.2 Laboratory Diagnostics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibodies
11.6.2 Kits and reagents
11.6.3 Labeling dyes
11.6.4 Species type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinical Research
11.10.2 Laboratory Diagnostics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibodies
12.6.2 Kits and reagents
12.6.3 Labeling dyes
12.6.4 Species type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinical Research
12.10.2 Laboratory Diagnostics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibodies
13.6.2 Kits and reagents
13.6.3 Labeling dyes
13.6.4 Species type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinical Research
13.10.2 Laboratory Diagnostics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunofluorescence Assays Market: Competitive Dashboard
14.2 Global Immunofluorescence Assays Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher (US)
14.3.2 Inova Diagnostics (US)
14.3.3 Bio-Rad (US)
14.3.4 Abcam (UK)
14.3.5 PerkinELmer (US)
14.3.6 Merck Millipore (US)
14.3.7 Cell Signaling Technology (US)
14.3.8 MEDIPAN GMBH (Germany)
14.3.9 Sino Biological (China)
14.3.10 Danaher (US)
14.3.11 Vector Laboratories (US)
